CHICAGO EQUITY PARTNERS LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 162 filers reported holding IMMUNOGEN INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q4 2019$437,000
+41.9%
85,660
-32.7%
0.02%
+66.7%
Q3 2019$308,000
-35.0%
127,305
+154.6%
0.02%
+7.1%
Q3 2018$474,000
-90.7%
50,006
-90.5%
0.01%
-91.1%
Q2 2018$5,124,000
-3.3%
526,660
+4.5%
0.16%
-7.1%
Q1 2018$5,300,000
+69.1%
503,765
+3.0%
0.17%
+76.0%
Q4 2017$3,135,000
-16.5%
489,035
-0.3%
0.10%
-19.3%
Q3 2017$3,753,000
+141.8%
490,635
+124.7%
0.12%
+183.3%
Q2 2017$1,552,000218,3200.04%
Other shareholders
IMMUNOGEN INC shareholders Q2 2017
NameSharesValueWeighting ↓
TWIN FOCUS CAPITAL PARTNERS, LLC 140,000$2,090,0002.48%
BB BIOTECH AG 3,165,816$47,266,0002.44%
SECTORAL ASSET MANAGEMENT INC 3,623,786$54,103,0002.22%
Lumbard & Kellner, LLC 81,225$1,192,0001.02%
Artal Group S.A. 1,300,000$19,409,0000.70%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 100,000$1,493,0000.48%
Rhenman & Partners Asset Management AB 73,702$1,100,0000.33%
PINNACLE ASSOCIATES LTD 883,647$13,193,0000.26%
FIRST TRUST ADVISORS LP 3,608,918$53,881,0000.24%
Granahan Investment Management 540,641$8,072,0000.22%
View complete list of IMMUNOGEN INC shareholders